lifestyle.careersavvy.co.uk

Author: Cue Biopharma, Inc.

Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

March 16, 2026
Cue Biopharma to Present New In vitro Data for CUE-401 at the 20th World Immune Regulation Meeting (WIRM) 2026

March 9, 2026
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases

February 20, 2026
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer

February 19, 2026